ArticlePakistan journal of medical sciences2025
Relationships of the expression levels of inflammatory factors in serum and cytokines in cerebrospinal fluid with the degree of postoperative nerve injury and prognosis in patients with Glioma.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the relationship between serum inflammatory markers (TNF-α, IL-6, CRP) and cerebrospinal fluid (CSF) cytokine levels (AVP, OT, β-EP) with the severity of postoperative neurological injury and prognosis in patients with glioma. Methodology: In this retrospective study, 80 patients with glioma who underwent surgery (study group) and 80 non-glioma controls who underwent CSF sampling (control group) were enrolled from Baoding No.1 Hospital between May 2023 and December 2024. Serum inflammatory factors (TNF-α, IL-6, CRP) and CSF cytokines (AVP, OT, β-EP) were measured in both groups. Neurological impairment was assessed using the NIH Stroke Scale (NIHSS). Comparative analyses were performed between groups and across different pathological stages and neurological injury severities. Multivariate logistic regression was used to identify risk factors affecting 3-year survival. Results: The study group showed significantly elevated levels of serum TNF-α, IL-6, CRP and CSF AVP, OT, β-EP compared to controls (p < 0.01). These markers increased with disease severity and higher pathological stage (III-IV vs. I-II, p < 0.01). Multivariate analysis identified TNF-α, IL-6, AVP, β-EP, pathological stage, degree of neurological injury, and extent of resection as independent risk factors for three years survival (p < 0.05). Conclusion: Elevated levels of serum inflammatory markers and CSF cytokines are associated with more severe neurological injury and worse prognosis in glioma patients. TNF-α, IL-6, AVP, and β-EP are independent risk factors for poor survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.